Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells

Oncogene

Volumn 33, Issue 34, 2014, Pages 4359-4364

  Barbetti, V ^a   Morandi, A ^a   Tusa, I ^a   Digiacomo, G ^a   Riverso, M ^a   Marzi, I ^a   Cipolleschi, M G ^a   Bessi, S ^b   Giannini, A ^b   Di Leo, A ^c   Dello Sbarba, P ^a   Rovida, E ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MISERICORDIA E DOLCE HOSPITAL   (Italy)

^c HOSPITAL OF PRATO   (Italy)

Author keywords

breast cancer; CSF 1; Fms; nuclear proteins; nuclear receptor tyrosine kinase

Indexed keywords

COLONY STIMULATING FACTOR 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN TYROSINE KINASE; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; C JUN GENE; CANCER CELL; CCND1 GENE; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; RECEPTOR BINDING;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; SOLUBILITY; TRANSCRIPTION, GENETIC;

EID: 84906934973     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.542     Document Type: Article

References (51)

1. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665-676
2. Stanley ER, Chen DM, Lin HS. Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature 1978; 274: 168-170
3. Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P et al. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci USA 2002; 99: 14404-14409
4. Kacinski BM. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol Reprod Dev 1997; 46: 71-74
5. Toy EP, Azodi M, Folk NL, Zito CM, Zeiss CJ, Chambers SK. Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor. Neoplasia 2009; 11: 136-144
6. Kirma N, Hammes LS, Liu YG, Nair HB, Valente PT, Kumar S et al. Elevated expression of the oncogene c-fms and its ligand, the macrophage colonystimulating factor-1, in cervical cancer and the role of transforming growth factorbeta1 in inducing c-fms expression. Cancer Res 2007; 67: 1918-1926
7. Morandi A, Barbetti V, Riverso M, DelloSbarba P, Rovida E. The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines. PLoS One 2011; 6: E27450
8. Kluger HM, Dolled-Filhart M, Rodov S, Kacinski BM, Camp RL, Rimm DL. Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clin Cancer Res 2004; 10: 173-177
9. Scholl SM, Pallud C, Beuvon F, Hacene K, Stanley ER, Rohrschneider L et al. Anticolony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 1994; 86: 120-126
10. Maher MG, Sapi E, Turner B, Gumbs A, Perrotta PL, Carter D et al. Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence. Clin Cancer Res 1998; 4: 1851-1856
11. Hamilton JA. CSF-1 signal transduction. J Leukoc Biol 1997; 62: 145-155
12. Wang YN, Yamaguchi H, Hsu JM, Hung MC. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene 2010; 29: 3997-4006
13. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001; 3: 802-808
14. Offterdinger M, Georget V, Girod A, Bastiaens PI. Imaging phosphorylation dynamics of the epidermal growth factor receptor. J Biol Chem 2004; 279: 36972-36981
15. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z et al. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 2004; 6: 251-261
16. Chioni AM, Grose R. FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior. J Cell Biol 2012; 197: 801-817
17. Johnston CL, Cox HC, Gomm JJ, Coombes RC. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J Biol Chem 1995; 270: 30643-30650
18. Stachowiak MK, Maher PA, Joy A, Mordechai E, Stachowiak EK. Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Brain Res Mol Brain Res 1996; 38: 161-165
19. Sehat B, Tofigh A, Lin Y, Trocme E, Liljedahl U, Lagergren J et al. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 2010; 3: Ra10
20. Seol KC, Kim SJ. Nuclear matrix association of insulin receptor and IRS-1 by insulin in osteoblast-like UMR-106 cells. Biochem Biophys Res Commun 2003; 306: 898-904
21. Feng Y, Venema VJ, Venema RC, Tsai N, Caldwell RB. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun 1999; 256: 192-197
22. Mayo LD, Kessler KM, Pincheira R, Warren RS, Donner DB. Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase. J Biol Chem 2001; 276: 25184-25189
23. Reilly JF, Maher PA. Importin beta-mediated nuclear import of fibroblast growth factor receptor: Role in cell proliferation. J Cell Biol 2001; 152: 1307-1312
24. Peng H, Moffett J, Myers J, Fang X, Stachowiak EK, Maher P et al. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell 2001; 12: 449-462
25. Kacinski BM, Scata KA, Carter D, Yee LD, Sapi E, King BL et al. FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 1991; 6: 941-952
26. Yee LD, Liu L. The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res 2000; 20: 4379-4383
27. Yeung YG, Wang Y, Einstein DB, Lee PS, Stanley ER. Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages. J Biol Chem 1998; 273: 17128-17137
28. Guilbert LJ, Stanley ER. The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages. J Biol Chem 1986; 261: 4024-4032
29. Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT et al. Upregulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. Gynecol Oncol 2008; 110: 445-451
30. Zwaenepoel O, Tzenaki N, Vergetaki A, Makrigiannakis A, Vanhaesebroeck B, Papakonstanti EA. Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110delta isoform of PI 3-kinase. FASEB J 2012; 26: 691-706
31. Bryant DM, Stow JL. Nuclear translocation of cell-surface receptors: Lessons from fibroblast growth factor. Traffic 2005; 10: 947-953
32. D'Angelo MA, Hetzer MW. Structure, dynamics and function of nuclear pore complexes. Trends Cell Biol 2008; 18: 456-466
33. Brameier M, Krings A, MacCallum RM. NucPred-predicting nuclear localization of proteins. Bioinformatics 2007; 23: 1159-1160
34. Offterdinger M, Schofer C, Weipoltshammer K, Grunt TW. c-erbB-3: A nuclear protein in mammary epithelial cells. J Cell Biol 2002; 157: 929-939
35. Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008; 320: 807-811
36. Shadle PJ, Aldwin L, Nitecki DE, Koths K. Human macrophage colony-stimulating factor heterogeneity results from alternative mRNA splicing, differential glycosylation, and proteolyticprocessing. J Cell Biochem 1989; 40: 91-107
37. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: Complexity in action. Trends Cell Biol 2004; 11: 628-638, Review
38. Mancini A, Koch A, Whetton AD, Tamura T. The M-CSF receptor substrate and interacting protein FMIP is governed in its subcellular localization by protein kinase C-mediated phosphorylation, and thereby potentiates M-CSF-mediated differentiation. Oncogene 2004; 39: 6581-6589
39. Roussel MF. Signal transduction by the macrophage-colony-stimulating factor receptor (CSF-1R). J Cell Sci Suppl 1994; 18: 105-108
40. Dittmann K, Mayer C, Rodemann HP. Nuclear EGFR as novel therapeutic target: Insights into nuclear translocation and function. Strahlenther Onkol 2010; 186: 1-6
41. Morgan C, Pollard JW, Stanley ER. Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5. J Cell Physiol 1987; 130: 420-427
42. Roussel MF, Sherr CJ. Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor. Proc Natl Acad Sci USA 1989; 86: 7924-7927
43. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011; 121: 2750-2767
44. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10: 515-527
45. Stanley ER, Heard PM. Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J Biol Chem 1977; 252: 4305-4312
46. Rovida E, Lugli B, Barbetti V, Giuntoli S, Olivotto M, DelloSbarba P. Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. Biol Chem 2005; 386: 919-929
47. Rovida E, Baccarini M, Olivotto M, DelloSbarba P. Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. Oncogene 2002; 21: 3670-3676
48. Rovida E, Spinelli E, Sdelci S, Barbetti V, Morandi A, Giuntoli S et al. ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. J Immunol 2008; 180: 4166-4172
49. Barbetti V, Gozzini A, Rovida E, Morandi A, Spinelli E, Fossati G et al. Selective antileukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ ETO-positive cells. Oncogene 2008; 27: 1767-1778
50. Barbetti V, Tusa I, Cipolleschi MG, Rovida E, DelloSbarba P. AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-Apoptotic effects of hypoxia. Cell Death Dis 2013; 4: E536
51. Barbetti V, Gozzini A, Cheloni G, Marzi I, Fabiani E, Santini V et al. Time-And residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells. Epigenetics 2013; 8: 210-219